Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$559,814
+$90,947 QoQ
Shares Held
1,127
+7.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,031
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $3,859,296 across 14 Biotechnology names. VRTX ranks #3 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OMER |
Omeros Corp
|
168,750 | $1,604,812 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
56,723 | $847,441 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,127 | $559,814 | |
| 4 | ANAB |
Anaptysbio, Inc
|
5,000 | $337,500 | |
| 5 | GLSI |
Greenwich LifeSciences, Inc.
|
10,740 | $251,960 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,215 | $175,627 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
2,500 | $44,925 | |
| 8 | INSM |
INSMED Inc
|
200 | $21,324 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $559,814 | 1,127 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $468,867 | 1,050 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $407,570 | 899 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $327,802 | 837 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $372,187 | 836 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $406,279 | 838 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $324,978 | 807 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $375,319 | 807 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $376,850 | 804 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $368,684 | 882 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $304,760 | 749 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $288,276 | 829 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $272,026 | 773 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $238,823 | 758 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $152,188 | 531 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $127,976 | 442 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $129,059 | 458 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $97,863 | 375 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $54,900 | 250 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $33,375 | 184 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $22,179 | 110 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $23,637 | 110 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $25,997 | 110 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $9,796 | 36 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $1,741 | 6 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $1,427 | 6 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||